Oral Vaccines Market Research Report and Forecast up to 2025 Oral Vaccines Market - Global Industry Analysis, S

Oral
Vaccines
Market
-
Global
Industry
Analysis, Size, Share, Growth, Trends, and
Forecast 2017 - 2025
Vaccination is termed as a cost-effective and efficient means of preventing various
infectious disorders. The use of common vaccines has curbed the widespread
transmission of diseases such as polio and measles in developing as well as
developed regions. Oral vaccines exhibit the potential to take immunization to a
new level of excellence. Although most vaccines are delivered via the parenteral
route, oral vaccines are considered to be a feasible & cost-effective alternative
employed for the prevention of non-mucosal transmitted infections. Orally
administered vaccines are processed by the digestive tract's immune system,
referred to as the gut-associated lymphoid tissue (GALT). To increase immunity
against vital disorders such as influenza and tuberculosis (TB), new oral vaccines
are being produced in developed countries.
Elimination of needles in the vaccination process and their safe & cost effective
nature are driving the oral vaccines market remarkably. The rising prevalence of
infectious diseases in developing countries, resistance to existing vaccines, and
bioterrorism are some of the factors expected to push the market from 2017 to
2025. However, oral vaccination is considered to be less effective compared to
vaccines administered via parenteral routes, as in the former method, antigens
undergo digestion in the gastrointestinal tract prior to the induction of immune
response. This could restrain the market over the forecast period.
View Report @ http://www.transparencymarketresearch.com/oral-vaccines-
market.html
The global oral vaccines market can be segmented on the basis of vaccine type into
the live (attenuated), inactive, recombinant, and other varieties. The inactive
segment accounted for a major chunk of the market revenue in 2016 due to its
safety and cost-effectiveness. It is likely to remain dominant over the forecast
period owing to the expanding patient pool in national immunization programs.
Based on application, the global oral vaccines market is divided into the following
categories: polio, rabies, tuberculosis, influenza, respiratory infections, HIV, cholera,
rotavirus, and others. The influenza and HIV segments constituted a major portion
of the revenue in 2016, due to their rising prevalence in developing countries. Oral
vaccines for tuberculosis, HIV, and influenza are projected to dominate the market
over the forecast period due to their increasing development by key players and
comparatively lower cost.